Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
Denise D. Correa, James C. Root, Maria Kryza‐Lacombe, et al.
Brain Imaging and Behavior (2016) Vol. 11, Iss. 6, pp. 1652-1663
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Chemotherapy-induced cognitive impairments: A systematic review of the animal literature
A. Matsos, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 382-399
Closed Access | Times Cited: 53
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis
Michiel B. de Ruiter, Rachael Deardorff, Jeroen Blommaert, et al.
Brain Imaging and Behavior (2023) Vol. 17, Iss. 5, pp. 507-518
Closed Access | Times Cited: 12
Unveiling Cognitive Impairment in Older Adults with Cancer on Systemic Anticancer Therapy: A Comprehensive Review
Rémi Fernandez, Gemma Fargas Baella, V. Slavova-Boneva, et al.
Drugs & Aging (2025)
Closed Access
Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice
XiaoJiao Huo, Teresa M. Reyes, Cobi J. Heijnen, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice
Angie C.A. Chiang, Alexandre V. Seua, Pooja Singhmar, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
Chemo-brain: An activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies
Lori J. Bernstein, Kim Edelstein, Alisha Sharma, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 314-325
Closed Access | Times Cited: 24
A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors
Kazuya Saita, S. Amano, Fumiko Kaneko, et al.
Frontiers in Human Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity
Naomi Lomeli, Diana C. Pearre, Maureen T. Cruz, et al.
Experimental Neurology (2024) Vol. 375, pp. 114717-114717
Open Access | Times Cited: 3
MicroRNA‑138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells
Miaomiao Qu, Yongning Zhu, Meng Jin
Experimental and Therapeutic Medicine (2018)
Open Access | Times Cited: 28
Structural brain alterations following adult non-CNS cancers: a systematic review of the neuroimaging literature
Ali Amidi, Lisa M. Wu
Acta Oncologica (2019) Vol. 58, Iss. 5, pp. 522-536
Open Access | Times Cited: 26
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Chemotherapy-induced functional changes of the default mode network in patients with lung cancer
Yujie Zhang, Yu‐Chen Chen, Lanyue Hu, et al.
Brain Imaging and Behavior (2019) Vol. 14, Iss. 3, pp. 847-856
Closed Access | Times Cited: 25
Chemotherapy-induced grey matter abnormalities in cancer survivors: a voxel-wise neuroimaging meta-analysis
Running Niu, Mingying Du, Jing Ren, et al.
Brain Imaging and Behavior (2020) Vol. 15, Iss. 4, pp. 2215-2227
Closed Access | Times Cited: 22
Self‐reported cognitive impairment in cervical cancer survivors: A cross‐sectional study
Elisabeth Wang Areklett, Elisabeth Fagereng, Kjersti Bruheim, et al.
Psycho-Oncology (2021) Vol. 31, Iss. 2, pp. 298-305
Open Access | Times Cited: 20
Neuropsychological assessment, intervention, and best practices for women with non-Central nervous system cancer: A scoping review of current standards
Hannah VanLandingham, Rachael L. Ellison, Nataliya Turchmanovych-Hienkel, et al.
The Clinical Neuropsychologist (2024) Vol. 38, Iss. 6, pp. 1334-1365
Closed Access | Times Cited: 2
Chemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics
Sandra Leskinen, Samir Alsalek, Rosivel Galvez, et al.
Neurology (2024) Vol. 104, Iss. 2
Closed Access | Times Cited: 2
miR‐153‐3p regulates progression of ovarian carcinoma in vitro and in vivo by targeting MCL1 gene
Cui Li, Yinmin Zhang, Wei Zhao, et al.
Journal of Cellular Biochemistry (2019) Vol. 120, Iss. 11, pp. 19147-19158
Closed Access | Times Cited: 22
Mapping cognitive deficits in cancer patients after chemotherapy: An Activation Likelihood Estimation meta-analysis of task-related fMRI studies
Jacqueline B Saward, Elizabeth G. Ellis, Annalee L. Cobden, et al.
Brain Imaging and Behavior (2022) Vol. 16, Iss. 5, pp. 2320-2334
Open Access | Times Cited: 9
Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen
Siwen Liu, Jie Ni, Fei Yan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Changes in functional brain networks and neurocognitive function in Chinese gynecological cancer patients after chemotherapy: a prospective longitudinal study
Yingchun Zeng, Andy S. K. Cheng, Ting Song, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Supramolecular Chemotherapy Based on the Host–Guest Complex of Lobaplatin–Cucurbit[7]uril
Yueyue Chen, Zhiwei Sun
ACS Applied Bio Materials (2020) Vol. 3, Iss. 4, pp. 2449-2454
Closed Access | Times Cited: 12
Cognitive Dysfunction
Robert J. Ferguson, Catherine M. Bender, Brenna C. McDonald, et al.
Springer eBooks (2018), pp. 199-225
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top